With the aging population and rising incidences of diseases linked to mitochondrial dysfunction, such as Alzheimer's and Parkinson's, the relevance of compounds like PQQ has become increasingly important. Efforts to understand the optimal dosages, bioavailability, and long-term effects of PQQ supplementation continue to evolve, paving the way for greater insights into its potential as a therapeutic agent.